Literature DB >> 15020704

Inhibition of hepatitis C virus IRES-mediated translation by small RNAs analogous to stem-loop structures of the 5'-untranslated region.

Partho Sarothi Ray1, Saumitra Das.   

Abstract

Translation of the hepatitis C virus (HCV) RNA is mediated by the interaction of ribosomes and cellular proteins with an internal ribosome entry site (IRES) located within the 5'-untranslated region (5'-UTR). We have investigated whether small RNA molecules corresponding to the different stem-loop (SL) domains of the HCV IRES, when introduced in trans, can bind to the cellular proteins and antagonize their binding to the viral IRES, thereby inhibiting HCV IRES-mediated translation. We have found that a RNA molecule corresponding to SL III could efficiently inhibit HCV IRES-mediated translation in a dose-dependent manner without affecting cap-dependent translation. The SL III RNA was found to bind to most of the cellular proteins which interacted with the HCV 5'-UTR. A smaller RNA corresponding to SL e+f of domain III also strongly and selectively inhibited HCV IRES-mediated translation. This RNA molecule interacted with the ribosomal S5 protein and prevented the recruitment of the 40S ribosomal subunit. This study reveals valuable insights into the role of the SL structures of the HCV IRES in mediating ribosome entry. Finally, these results provide a basis for developing anti-HCV therapy using small RNA molecules mimicking the SL structures of the 5'-UTR to specifically block viral RNA translation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15020704      PMCID: PMC390326          DOI: 10.1093/nar/gkh328

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  Antisense and sensibility.

Authors:  Alan Dove
Journal:  Nat Biotechnol       Date:  2002-02       Impact factor: 54.908

Review 2.  Therapy of hepatitis C: overview.

Authors:  K L Lindsay
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

3.  Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines.

Authors:  C H Wu; G Y Wu
Journal:  Gastroenterology       Date:  1998-06       Impact factor: 22.682

4.  Specific interaction of a 25-kilodalton cellular protein, a 40S ribosomal subunit protein, with the internal ribosome entry site of hepatitis C virus genome.

Authors:  S Fukushi; M Okada; T Kageyama; F B Hoshino; K Katayama
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

5.  Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach.

Authors:  M Kruger; C Beger; Q X Li; P J Welch; R Tritz; M Leavitt; J R Barber; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

6.  Vitamin B12 and hepatitis C: molecular biology and human pathology.

Authors:  W B Lott; S S Takyar; J Tuppen; D H Crawford; M Harrison; T P Sloots; E J Gowans
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

7.  La autoantigen is required for the internal ribosome entry site-mediated translation of Coxsackievirus B3 RNA.

Authors:  Partho Sarothi Ray; Saumitra Das
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

8.  Ribosomal protein S5 interacts with the internal ribosomal entry site of hepatitis C virus.

Authors:  S Fukushi; M Okada; J Stahl; T Kageyama; F B Hoshino; K Katayama
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

9.  Internal ribosome entry site within hepatitis C virus RNA.

Authors:  K Tsukiyama-Kohara; N Iizuka; M Kohara; A Nomoto
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation.

Authors:  Béatrice Tallet-Lopez; Lydia Aldaz-Carroll; Sandrine Chabas; Eric Dausse; Cathy Staedel; Jean-Jacques Toulmé
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

View more
  12 in total

1.  Reversible induction of translational isoforms of p53 in glucose deprivation.

Authors:  D Khan; A Katoch; A Das; A Sharathchandra; R Lal; P Roy; S Das; S Chattopadhyay; S Das
Journal:  Cell Death Differ       Date:  2015-02-27       Impact factor: 15.828

2.  Two internal ribosome entry sites mediate the translation of p53 isoforms.

Authors:  Partho Sarothi Ray; Richa Grover; Saumitra Das
Journal:  EMBO Rep       Date:  2006-01-20       Impact factor: 8.807

Review 3.  Searching for IRES.

Authors:  Stephen D Baird; Marcel Turcotte; Robert G Korneluk; Martin Holcik
Journal:  RNA       Date:  2006-09-06       Impact factor: 4.942

4.  Re-analysis of cryoEM data on HCV IRES bound to 40S subunit of human ribosome integrated with recent structural information suggests new contact regions between ribosomal proteins and HCV RNA.

Authors:  Agnel Praveen Joseph; Prasanna Bhat; Saumitra Das; Narayanaswamy Srinivasan
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

5.  Targeting ribosome assembly on the HCV RNA using a small RNA molecule.

Authors:  Prasanna Bhat; Sivakumar Vadivel Gnanasundram; Prashant Mani; Partho Sarothi Ray; Debi P Sarkar; Saumitra Das
Journal:  RNA Biol       Date:  2012-08-01       Impact factor: 4.652

6.  Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics.

Authors:  Robert Smolic; Martina Smolic; John H Andorfer; Catherine H Wu; Robert M Smith; George Y Wu
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

7.  A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.

Authors:  Renuka Pudi; Sudhamani S Ramamurthy; Saumitra Das
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 8.  Hepatitis C virus translation inhibitors targeting the internal ribosomal entry site.

Authors:  Sergey M Dibrov; Jerod Parsons; Maia Carnevali; Shu Zhou; Kevin D Rynearson; Kejia Ding; Emily Garcia Sega; Nicholas D Brunn; Mark A Boerneke; Maria P Castaldi; Thomas Hermann
Journal:  J Med Chem       Date:  2013-11-05       Impact factor: 7.446

9.  A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId.

Authors:  Kunio Kikuchi; Takuya Umehara; Kotaro Fukuda; Atsushi Kuno; Tsunemi Hasegawa; Satoshi Nishikawa
Journal:  Nucleic Acids Res       Date:  2005-01-28       Impact factor: 16.971

10.  Secondary Structural Elements of the HCV X-region Involved in Viral Replication.

Authors:  Nidhi Gupta; Catherine H Wu; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2015-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.